Geom Therapeutics is Drug Discovery in United States that focus on resistant aeruginosa business. Founded in 2016. They cover business area such as developer, novel antibiotic, broad-spectrum coverage, activity, multi-drug resistant, superior survival, ceftazidime, doripenem, resistant aeruginosa systemic infection model, patient, multidrug-resistant gram-negative infection.
2016
( 8 years old in 2024 )
Resistant Aeruginosa
-
826A Vallejo Street
San Francisco, CA 94133
United States
Private
developernovel antibioticbroad-spectrum coverageactivitymulti-drug resistantsuperior survivalceftazidimedoripenemresistant aeruginosa systemic infection modelpatientmultidrug-resistant gram-negative infection
* We use standard office opening hours in near Geom Therapeutics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Geom Therapeutics is Drug Discovery business from United States that founded in 2016 (8 years old in 2024), Geom Therapeutics business is focusing on Resistant Aeruginosa.
Geom Therapeutics headquarter office and corporate office address is located in 826A Vallejo Street San Francisco, CA 94133 United States.
Geom Therapeutics was founded in United States.
In 2024, Geom Therapeutics is currently focus on resistant aeruginosa sector.
Above is snippet of Google Trends for "resistant aeruginosa" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Geom Therapeutics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
